Clinical Observation on Modified Pulsatilla Decoction（白头翁汤） for Enema Treating Acute Period of Ulcerative Colitis of Left Hemicolon Type: Report of 17 Cases

DAI Gaozhong; CHEN Chen; FAN Xianjing; ZHOU Chungang; ZHU Shikai

doi:10.13288/j.11-2166/r.2015.21.016

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on Modified Pulsatilla Decoction（白头翁汤） for Enema Treating Acute Period of Ulcerative Colitis of Left Hemicolon Type: Report of 17 Cases

更新时间：2021-11-17

- Clinical Observation on Modified Pulsatilla Decoction（白头翁汤） for Enema Treating Acute Period of Ulcerative Colitis of Left Hemicolon Type: Report of 17 Cases
- Journal of Traditional Chinese Medicine Vol. 56, Issue 21, Pages: 1862-1866(2015)
- 作者机构：
  
  1. 无锡市中医医院
  2. 南京中医药大学研究生院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2015.21.016
  CLC： R259
- Published：2015
- 稿件说明：
移动端阅览
[1]戴高中,陈晨,范先靖,周春刚,朱世楷.白头翁汤加减灌肠方治疗左半结肠型急性期溃疡性结肠炎17例临床观察[J].中医杂志,2015,56(21):1862-1866.

DAI Gaozhong, CHEN Chen, FAN Xianjing, et al. Clinical Observation on Modified Pulsatilla Decoction（白头翁汤） for Enema Treating Acute Period of Ulcerative Colitis of Left Hemicolon Type: Report of 17 Cases[J]. Journal of Traditional Chinese Medicine2015, 56(21): 1862-1866.
[1]戴高中,陈晨,范先靖,周春刚,朱世楷.白头翁汤加减灌肠方治疗左半结肠型急性期溃疡性结肠炎17例临床观察[J].中医杂志,2015,56(21):1862-1866. DOI： 10.13288/j.11-2166/r.2015.21.016.

DAI Gaozhong, CHEN Chen, FAN Xianjing, et al. Clinical Observation on Modified Pulsatilla Decoction（白头翁汤） for Enema Treating Acute Period of Ulcerative Colitis of Left Hemicolon Type: Report of 17 Cases[J]. Journal of Traditional Chinese Medicine2015, 56(21): 1862-1866. DOI： 10.13288/j.11-2166/r.2015.21.016.

摘要

目的观察白头翁汤加减灌肠方治疗左半结肠型急性期溃疡性结肠炎的临床疗效及可能作用机制。方法选取34例左半结肠型急性期溃疡性结肠炎患者随机分成治疗组和对照组各17例。治疗组予白头翁汤加减灌肠方保留灌肠

每日1剂

每日1次

对照组予柳氮磺胺吡啶灌肠

每次1 g

每日2次

疗程均为45天。治疗前后比较两组中医证候评分及结肠黏膜病变评分

测定肠黏膜白细胞介素8（IL-8）的表达

判定中医证候疗效。结果两组患者治疗后腹泻、脓血便、腹痛、腹胀、里急后重、纳呆、乏力症状评分及总积分均较本组治疗前下降（P<0.05或P<0.01）;治疗组治疗后腹泻、脓血便、腹痛症状评分及总积分较对照组下降明显（P<0.05）。治疗组与对照组的中医证候疗效总有效率分别为94.11%和76.47%

差异有统计学意义（P<0.05）。两组治疗后镜下结肠黏膜病变评分及IL-8的表达均较本组治疗前明显改善（P<0.01）。治疗组结肠黏膜病变评分显著低于对照组（P<0.05）

IL-8表达强度与对照组比较

差异无统计学意义（P>0.05）。结论白头翁汤加减灌肠方能改善左半结肠型急性期溃疡性结肠炎患者的临床症状、修复黏膜组织

其机制可能与下调肠黏膜IL-8的表达有关。

Abstract

Objective To observe clinical effects and possible mechanism of Modified Pulsatilla Decoction for enema treating acute period of ulcerative colitis of left hemicolon type. Methods Totally 34 cases of patients with acute period of ulcerative colitis of left hemicolon type were randomly divided into treatment group and control group

with 17 cases in each group. Gave treatment group Modified Pulsatilla Decoction for retention enema

1 dose per day

once every day. Gave control group Sulfasalazine for enema

1 g each time

twice per day. Treatment course was 45 days both. Compared Chinese medicine syndrome scores and colon mucosa lesion of the two groups before and after treatment. Tested the expression of intestinal mucosa interleukin-8（ IL-8）

and evaluated the treatment effect of Chinese medicine syndrome. Results Symptom scores and aggregate scores of diarrhea

bloody purulent stool

abdominal pain

abdominal distention

tenesmus

anorexia and feeble of two groups after treatment decreased compared with those before treatment（ P < 0. 05 or P < 0. 01）. Symptom scores and aggregate scores of diarrhea

bloody purulent stool

abdominal pain of treatment group after treatment remarkably decreased compared with those of control group（ P < 0. 05）. Total effective rate of Chinese medicine syndrome of treatment group and control group was respectively 94. 11% and 76. 47%. The difference was statistically significant（ P < 0. 05）. Microscopy colon mucosa lesion score and expression of IL-8 all remarkably improved compared with those before treatment（ P < 0. 01）. Colon mucosa lesion score of treatment group was remarkably lower than that of control group（ P < 0. 05）. Difference of expressional intensity of IL-8 was not statistically significant compared with that of control group（ P > 0. 05）. Conclusion Modified Pulsatilla Decoction for enema could improve clinical symptom and repair mucosal tissue of patients with acute period of ulcerative colitis of left hemicolon type. Its mechanism may be related to down-regulating expression of IL-8 in intestinal mucosa.

关键词

Keywords

references

查看原文

Views

834

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Comparative Study on the Effects of Qingchang Wenzhong Decoction （清肠温中方） on the Intestinal Mucus Barrier in Conventional and Pseudo-Germ-Free Model Mice of Acute Ulcerative Colitis

Prevention and Treatment of the Relapse of Ulcerative Colitis Based on the Theory of Damp-Heat Latent Pathogen

Characteristics of Traditional Chinese Medicine Syndromes and Treatment Rules in Ulcerative Colitis Patients in Jiangsu Province：Based on Real-World Data

Clinical Efficacy of Shenyu Guanchang Formula （参榆灌肠方） Enema Combined with Oral Mesalazine in the Treatment of Left-Sided Ulcerative Colitis with Large Intestine Damp-Heat Syndrome and Network Pharmacology Research

Traditional Chinese Medicine Therapy for Active Ulcerative Colitis：A Multicenter Bidirectional Cohort Study

Related Author

GAO Mingxu

LIU Leilei

LU Lijie

WANG Jiali

HU Juncong

LIN Yangzhe

LIU Qirui

DONG Yue

Related Institution

Dongfang Hospital，Beijing University of Chinese Medicine

School of Traditional Chinese Medicine，Beijing University of Chinese Medicine

Institute of Spleen and Stomach Diseases，Xiyuan Hospital，China Academy of Chinese Medical Sciences

Jiangsu Province Hospital of Chinese Medicine/Affiliated Hospital of Nanjing University of Chinese Medicine

Jiangsu Provincial Hospital of Chinese Medicine/Affiliated Hospital of Nanjing University of Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰